Dr. Asche, former managing director of BLS Analytik GmbH, says that "the merger is a great enrichment for our customers in the field of pharmaceutical quality control and biocompatibility testing of medical devices. The range of methods and analyses has become even larger as a result of the merger of the three companies." Dr. Herzog, former managing director of TentaMedix GmbH agrees, "We can offer a one stop shop for our clients, while maintaining a high level of analysis quality and customer communication".

The three locations of Tentamus Pharma & Med Deutschland GmbH are GMP certified and the sites in Bad Kissingen and Karlsruhe are also accredited according to DIN EN ISO/IEC 17025. The location in Bad Kissingen is able to support its customers in the pharmaceutical industry and medical technology with state of the art instrumental analysis and a wide range of analytics. The quality control laboratory with its reliable and high quality wet chemical and instrumental analytics (LC, GC, elemental analytics) will be an important part of the new company.

The location in Oldenburg, which holds a manufacturing authorisation according to §13 AMG, has a long track record in the field of pharmaceutical analytical development. In addition to the extensive portfolio of analytics, the Oldenburg site also offers rich experience in the field of method development and validation as well as in ICH compliant stability studies.

The third location in Karlsruhe provides a wide range of microbiological, molecular biological and bioanalytical methods. In addition, this location is accredited and recognized by the ZLG for in vitro biocompatibility testing of medical devices (DIN EN ISO 10993). Thus, in addition to the chemical analytical methods, the biological safety of medicinal products and medical devices can also be examined by Tentamus Pharma & Med Deutschland GmbH.

Tentamus Pharma & Med Deutschland GmbH is therefore the place to go for testing pharmaceutical products and medical devices. We look forward to your enquiry.